AaronKopmanMD

PubMed

• 46 citations
  The "intubating dose" of succinylcholine: the effect of decreasing doses on recovery time.
  Aaron F. Kopman, Bledi Zhaku, Kane S. Lai
  Anesthesiology. 2003-11-01
• 228 citations
  Relationship of the Train-of-four Fade Ratio to Clinical Signs and Symptoms of Residual Paralysis in Awake Volunteers
  Aaron F. Kopman, Pamela S. Yee, George G. Neuman
  Anesthesiology. 1997-04-01
• 166 citations
  Current Status of Neuromuscular Reversal and Monitoring: Challenges and Opportunities.
  Sorin J. Brull, Aaron F. Kopman
  Anesthesiology. 2017-01-01

Journal Articles

• The TOF-Watch(R) monitor: Failure to calculate the TOF ratio in the absence of baseline calibration in anaesthetized dogs  
  Martin-Flores M, Gleed RD, Basher K, Scarlett J, Campoy L, Kopman AF, Br J Anaesth, 1/1/2012
• Neuromuscular dose-response studies. Determining sample size  
  Kopman AF, Lien CA, Naguib M, Br J Anaesth, 1/1/2011
• Determining the potency of neuromuscular blockers: Are traditional methods flawed?  
  Kopman AF, Lien CA, Naguib M, Br J Anaesth, 1/1/2010
• A survey of current neuromuscular practice in the United States and Europe  
  Naguib M, Kopman AF, Lien CA, Hunter JM, Lopez A, Brull SJ, Anesth Analg, 1/1/2010
• Neuromuscular monitoring and postoperative residual curarisation: a meta-analysis  
  Naguib M, Kopman AF, Ensor JE, British Journal of Anaesthesia, 1/1/2007
• Acceleromyography versus electromyography: An ipsilateral comparison of the indirectly evoked neuromuscular response to train-of-four stimulation  
  Kopman AF, Chin W, Cyriac J, Acta Anaesthesiologica Scandinavica, 1/1/2005
• Dose-response relationship of rocuronium. A comparison of electromyographic vs. acceleromyographic-derived values  
  Kopman AF. Chin WA, Acta Anaesthesiologica Scandinavica, 1/1/2005
• The effect of nitrous oxide on the dose-response relationship of rocuronium  
  Kopman AF, Chin W, Moe J, Malik R, Anesthesia & Analgesia, 1/1/2005
• Antagonism of profound cisatracurium and rocuronium block: The role of objective assessment of neuromuscular function  
  Kopman AF, Kopman DJ, Ng J, Zank L, J Clin Anesth, 1/1/2005
• Antagonism of cisatracurium and rocuronium block at a tactile train-of-four count of two. Should quantitative assessment of neuromuscular function be mandatory?  
  Kopman AF, Zank LM, Ng J, Neuman GG, Anesth Analg, 1/1/2004
• Model to describe the degree of twitch potentiation during neuromuscular monitoring  
  Eleveld DJ, Kopman AF; Proost JH, Wierda JM, Br J Anaesth, 1/1/2004
• The “intubating dose of succinylcholine.” The effect of decreasing doses on recovery time  
  Kopman AF, at al, Anesthesiology, 1/1/2003
• Low-dose rocuronium and tracheal intubation  
  Naguib M, Kopman AF, Middle East Journal of Anesthesiology, 1/1/2003
• Acceleromyography as a guide to anesthetic management. A case report  
  Kopman AF, Sinha N, J Clin. Anesth, 1/1/2003
• The relationship between acceleromyographic train-of-four fade and single twitch depression  
  Kopman AF, Klewicka MM, Neuman GG, Anesthesiology, 1/1/2002
• Precurarization and priming: A theoretical analysis of safety and timing  
  Kopman AF, Kahn N, Neuman GG, Anesth Analg, 1/1/2001
• Reexamined: The recommended “intubating dose” for nondepolarizing blockers of rapid-onset  
  Kopman AF, Klewicka MM, Neuman GG, Anesth Analg, 1/1/2001
• The staircase phenomenon. Implications for monitoring of neuromuscular transmission  
  Kopman AF, Kumar S, Klewicka MM, Neuman GG, Anesthesiology, 1/1/2001
• Pharmacokinetic studies of neuromuscular blocking agents: Good clinical research practice (GCRP)  
  Viby-Mogensen J, Ostergaard D, Fisher D, Hunter J, Kampmann JP, Kopman AF, Proost H, Rasmussen SN, Skovgaard LT, Varin F, Wright PMC, Acta Anaesthesiol Scand, 1/1/2000
• Dose-response and onset/offset characteristics of rapacuronium  
  Kopman AF, Klewicka MM, Neuman GG, Flores F, Ghori K, Anesthesiology, 1/1/2000
• An alternate method of estimating the dose-response relationships for neuromuscular blocking drugs  
  Kopman AF, Klewicka MM, Neuman GG, Anesth Analg, 1/1/2000
• Molar potency is predictive of the speed of onset of neuromuscular block for agents of intermediate-, short-, and ultra-short duration  
  Kopman, AF, Klewicka MM, Kopman DJ, Neuman GG, Anesthesiology, 1/1/1999
• Molar Potency is not predictive of the speed of onset of atracurium  
  Kopman, AF, Klewicka MM, Neuman GG, Anesth Analg, 1/1/1999
• Correlation of the train-of-four fade ratio with clinical signs and symptoms of residual curarization in awake volunteers  
  Kopman AF, Yee PS, Neuman GG, Anesthesiology, 1/1/1997
• Post-operative residual paralysis. Pancuronium versus mivacurium; does it matter  
  Kopman AF, Ng J, Zank LM, Neuman GG, Yee PS, Anesthesiology, 1/1/1996
• Join now to see all

Books/Book Chapters

• Current Anesthesiology Reports 
  Chapter: Management Principles to Reduce the Risk of residual neuromuscular blockade 
  Page 130 - 138Brull SJ, Kopman AF, Naguib M2013
• Yao & Artusio’s Anesthesiology: Problem-Oriented Patient Management 
  Chapter: Prolonged post-operative apnea and residual neuromuscular weakness 
  Page 1184 - 1199Kopman D, Kopman AFEditors: Fun-Sun F. Yao..Lippincott Williams & Wilkens, Philadelphia, PAEdition 7th ,2012
• Monitoring in Anesthesia and Perioperative Care. David Reich Editor 
  Chapter: Neuromuscular monitoring 
  Page 261 - 280Kopman AFCambridge University Press, NY2011
• ASA Refresher Courses in Anesthesiology 
  Chapter: Monitoring neuromuscular function. Facts and fallacies 
  Page 72 - 79Kopman AFLippincott Williams & Wilkins, Philadelphia, PA2011
• Controversial Drugs in Clinical Practice. Audio-Digest Anesthesiology 
  Chapter: Succinylcholine: A marvel whose time has passed? 
  Kopman AF2008
• Residual neuromuscular block has consequences 
  Page 363 - 364Kopman AF2008
• Seminars in Anesthesia, Perioperative Medicine and Pain 
  Chapter: Neuromuscular blocking agents: New insights and old controversies 
  Page 75 - 85Kopman AF2002
• Current Opinion in Anesthesiology 
  Chapter: Measurement and monitoring of neuromuscular blockade 
  Page 415 - 420Kopman AF2002
• Geriatric Anesthesiology 
  Chapter: Clinical use of relaxants in the geriatric patient 
  Kopman AFEditors: McKleskey CH.Williams & Wilkins, Baltimore1996
• Muscle Relaxants: Physiologic and Pharmacologic Aspects 
  Chapter: Reversal of mivacurium: neostigmine, edrophonium, or spontaneous recovery - Which makes more sense? 
  Kopman AFEditors: Fukushima K, Ochiai R.Springer-Verlag, Tokyo1995
• Clinical pharmacology and practical applications of neuromuscular blockers and antagonists 
  Chapter: Clinical pharmacology and practical applications of neuromuscular blockers and antagonists 
  Lein CA, Savarese JJ, Kopman AFEditors: Bowdle TA.Churchill Livingstone, NY1994
• Anesthesiology Clinics of North America 
  Chapter: What is really new about the new relaxants? 
  Page 729 - 778Lien CA, Belmont MR, Kopman AF, Savarese JJEditors: Ornstein E.W. B. Saunders Co., Philadelphia1993
• Refresher Courses in Anesthesiology 
  Chapter: New and currently available muscle relaxants 
  Page 255 - 282Lien CA, Belmont MR, Kopman AF, Savarese JJJ. P. Lippincott1993
• Progress in Anesthesiology 
  Chapter: Reversal of neuromuscular blockade 
  Kopman AFDannemiller Memorial Educational Foundation, San Antonio, TX1992
• Anesthesiology Review 
  Chapter: Recovery and reversal of neuromuscular blocking agents: Ambulatory surgery considerations 
  Page 21 - 27Kopman AF1990
• Problems in Anesthesia: Neuromuscular Relaxants 
  Chapter: Antagonism of profound neuromuscular blockade 
  Kopman AFEditors: Stephen M.Rupp, Lippincott, Philadelphia1989
• Current Opinion in Anaesthesiology 
  Chapter: Neuromuscular blocking drugs: Recovery and reversal 
  Kopman, AF1988
• Problems in Anesthesia: A Case Study Approach 
  Chapter: Differential diagnosis of hypercarbia 
  Page 29 - 38Kopman AFEditors: Mark Ravin.Little Brown & Co., N.Y.1981
• Join now to see all

Abstracts/Posters

• Optimal sample size for determining potency of neuromuscular blocking agents
  Kopman AF, Lien CA, Br J Anaesth, 1/1/2009
• Acceleromyography versus electromyography: An ipsilateral comparison of the indirectly evoked neuromuscular response to train-of-four stimulation
  Kopman AF, Chin W, Cyriac J, Anesthesiology, 1/1/2004
• The effect of an elastic preload on the acceleromyographic recorded response of the adductor pollicis to indirect stimulation
  Chin WA, Kopman AF., Anesthesiology, 1/1/2004
• A dose-response study of rocuronium. Do acceleromyographic and electromyographic monitors produce the same results?
  Kopman AF. Chin WA., Anesthesiology, 1/1/2004
• Dose-response relationships of 430A under propofol, nitrous oxide, opioid anesthesia
  Belmont MR, Lien CA, Tjan J, Patel SS, Kopman AF, 2003 ASA Annual Meeting, 1/1/2003
• Reexamined: The recommended “intubating dose” for nondepolarizing blockers of rapid-onset
  Kopman AF, Klewicka MM, Neuman GG, 2001 ASA Meeting, New Orleans, 1/1/2001
• Patterns and costs of pre-operative Testing: Preop clinic vs. outside testing
  Mathews D, Klewicka M, Kopman AF, Neuman GG, Anesthesiology, 1/1/2000
• Ability of the bispectral index (BIS) to predict verbal responsiveness in patients undergoing intravenous sedation
  Mathews D, Greenwald S, Kumar S, Kopman AF, Neuman G, Anesthesiology, 1/1/2000
• Dose-response and onset/offset characteristics of rapacuronium
  Kopman AF, Klewicka MM, Neuman GG, Flores F, Ghori K, Anesthesiology, 1/1/2000
• Molar potency is not predictive of the speed of onset of atracurium. Abstract presented. Annual Meeting American Soc. Anesthesiology
  Kopman AF, Klewicka MM, Neuman GG, Anesthesiology, 10/1/1999
• Onset of neuromuscular block following subparalyzing doses of cisatracurium, vecuronium, rocuronium, and succinylcholine
  Kopman AF, Klewicka MM, Kopman DJ, Neuman GG, Anesthesiology, 1/1/1998
• Post-operative residual curarization: Pancuronium versus mivacurium
  Kopman AF, American Society of Anesthesiologist Annual Meeting, 10/1/1996
• Post-operative residual curarization: Pancuronium versus mivacurium
  Kopman AF, Ng J, Zank L, Neuman GG, Yee P, Anesthesiology, 1/1/1996
• The influence of electrode placement of EMG amplitude and subjective pain
  Fernandes L, Brull S, Printsev Y, Silverman D, Kopman AF, Anesthesiology, 1/1/1995
• Respiratory function in the PACU: Results of a phase IV study of mivacurium and vecuronium
  Roizen MF, Walawander CA, Grasela TH, Viby Mogensen J, Apfelbaum JL, Kopman AF, McLeskey CH, Nabulsi A, Anesth Analg, 1/1/1995
• Comparison oh the recovery profile of mivacurium and vecuronium in 1,163 patients
  Apfelbaum JL, Grasela TH, Kopman AF, McLeskey CH, Nabulsi A, Roizen MF, Viby Mogensen J, Thirsted RA, Walawander CA, Anesth Analg, 1/1/1995
• Frequency and importance of mivacurium-induced flushing
  McLeskey CH, Walawander CA, Nabulsi A, Roizen MF, Viby-Mogensen J, Thited RA, Apfelbaum JL, Grasela TH, Kopman AF, Anesthesiology, 1/1/1994
• Postoperative nausea/vomiting and the effect of anticholinesterase agents
  Grasela TH, McLeskey CH, Walawander CA, Kopman AF, Nabulsi A, Roizen MF, Viby-Mogensen J, Thited RA, Apfelbaum JL, Anesthesiology, 1/1/1994
• Train-of-four count as an indicator of the extent of neuromuscular block: A reappraisal
  Kopman AF, Mallhi M, Justo M, Rodricks P, Anesthesiology, 1/1/1994
• Incidence of post-dural puncture headache in outpatient arthroscopy using a 27 gauge Whitacre needle
  Smyth JP, Spenser JT, Kopman AF, Anesthesiology, 1/1/1993
• Efficacy and safety of divided dose administration of mivacurium for rapid tracheal intubation
  Ali HH, Brull S, Witkowski T, Kopman AF, Silverman D, Anesthesiology, 1/1/1993
• Join now to see all

Lectures

• Post-operative residual neuromuscular block and its clinical consequences 
  6/1/2013
• Undetected post-operative residual neuromuscular block. It’s more common than you think 
  4/1/2013
• Post-operative residual neuromuscular block: Incidence and consequences 
  1/1/2013
• Anesthesia Patient Safety Foundation panel: Residual muscle relaxant induced weakness in the postoperative period. Is it a patient safety issue? 
  12/1/2012
• Refresher Course Lecture: Monitoring perioperative neuromuscular function. Facts, fallacies and controversies 
  10/1/2011
• Managing intra-operative neuromuscular block: Facts, fallacies, and unmet needs 
  11/1/2010
• Refresher Course Lecture: Monitoring perioperative neuromuscular function. Facts and fallacies 
  10/1/2010
• Neuromuscular block for short procedures & new developments in reversal strategies 
  12/1/2009
• The ED95, current controversies. Implications for the clinician 
  7/1/2009
• Undetected post-operative neuromuscular block has clinical implications 
  12/1/2008
• Neuromuscular blocking agents; Current controversies and a peek into the future 
  10/1/2008
• Resident Research Forum 
  10/1/2008
• Unmet clinical needs in anesthesiology 
  10/1/2008
• Neuromuscular block. Hot topics 2007 
  12/1/2007
• Is it time to retire succinylcholine? 
  12/1/2007
• Recovery from nondepolarizing blockers: Current problems and future solutions 
  10/1/2007
• Novel neuromuscular blocking and reversal agents 
  10/1/2007
• Muscle Relaxants 2007: Current issues 
  6/1/2007
• Post-operative residual curarization: Is it a real problem? Is it preventable? 
  3/1/2007
• Miniworkshop: Should objective monitoring of neuromuscular block be mandatory? Will sugammadex change current standards? 
  12/1/2006
• What Is the Future of Reversal Agents for Antagonism of Non-Depolarizing Neuromuscular Blockade? 
  10/1/2006
• Scientific Papers Session 
  10/1/2005
• Acceleromyography 
  6/1/2005
• Miniworkshop: Is objective monitoring of neuromuscular block mandatory? 
  12/1/2004
• Moderator, scientific papers session 
  10/1/2004
• Join now to see all

Other

• Postanesthesia evaluation of neuromuscular function 
  Kopman AF
  1/1/2013
• Low dose sugammadex. There is no free lunch 
  Kopman AF, Brull SJ
  1/1/2013
• Is post-operative residual neuromuscular block associated with adverse clinical outcomes? What is the evidence? 
  Kopman AF, Brull SJ
  1/1/2013
• Rescue reversal: An addendum 
  Kopman AF, Kurata J
  1/1/2012
• Clinical experience: A potential hazard 
  Kopman AF
  1/1/2012
• "Can't-Intubate, Can't-Ventilate." Is Rescue Reversal a Pipe-Dream? 
  Kopman AF, Kurata J
  1/1/2012
• A survey of practice of neuromuscular block in the United States and Europe: A response 
  Naguib M, Kopman AF, Lien CA, Hunter JM, Brull SJ
  1/1/2011
• Neuromuscular Block: Not only Czech beer deserves a taste: In response 
  Kopman AF
  1/1/2011
• Sugammadex dose requirements at post-tetanic counts of one to two. Cost implications 
  Kopman AF
  1/1/2010
• Determining the potency of neuromuscular blockers. A response 
  Kopman AF, Lien CA, Naguib M
  1/1/2010
• Neostigmine vs. Sugammadex: Which, when and how much? 
  Kopman AF
  1/1/2010
• Managing Neuromuscular Block: Where are the guidelines? 
  Kopman AF
  1/1/2010
• How low can you go? Lowest effective muscle relaxant dose for tracheal intubation 
  Kopman AF
  1/1/2009
• Neuromuscular monitoring: Old issues – new controversies 
  Kopman AF
  1/1/2009
• Reversal of nondepolarizing neuromuscular blockers: Current practice 
  Kopman AF, Eikerman M
  1/1/2009
• Residual neuromuscular block and adverse respiratory events 
  Kopman AF
  1/1/2008
• Sugammadex-rocuronium dosing 
  Kopman AF
  1/1/2007
• Neuromuscular monitoring and postoperative residual curarisation: A response 
  Naguib M, Kopman AF, Ensore JE
  1/1/2007
• An analysis of the TOF-Watch algorithm for modifying the displayed train-of-four fade ratio 
  Kopman AF, Kopman DJ
  1/1/2006
• Rocuronium vs. succinylcholine for rapid tracheal intubation 
  Kopman AF
  1/1/2006
• Can conventional peripheral nerve stimulators induce direct muscle depolarization? 
  Kopman AF
  1/1/2006
• The Datex-Ohmeda M-NMT module. A potentially confusing user interface 
  Kopman AF
  1/1/2006
• Sugammadex: A revolutionary approach to neuromuscular antagonism 
  Kopman AF
  1/1/2006
• Monitoring neuromuscular blockade often overlooked 
  Kopman AF
  1/1/2005
• Normalization of the acceleromyographic train-of-four fade ratio 
  Kopman AF
  1/1/2005
• Join now to see all